Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
… as promising treatments for these conditions. T cell engagers (TCEs) provide a more direct and robust mechanism for targeting B cel…
…an tumor patient samples representing a variety of indications. INDUCER™ molecules that target tumor-associated antigens exhibited potent cytotoxi…
…Abstract T cell engagers (TCEs) recruit T cells to the tumor microenvironment (TME) to induce …
…ed significantly improved tolerability compared with non-masked TCEs, with reduced systemic cytokine release and body weight loss. I…
…Background T cell engagers (TCEs) are clinically successful bispecific antibodies, albeit primar…
…T-cell engagers (TCEs) have emerged as a promising tool to perform a ‘deep’ depletion…
…Background Bispecific T cell engager (BiTE), such as blinatumomab, has demonstrated significant clinical success in treating hema…
…Background T cell engagers (TCEs) are powerful therapeutics which can kill cells expressing low …
…cell killing efficacy to clinically validated molecules such as tebentafusp.Conclusions In this work, we showcase the discovery and enginee…